Furthermore, tumor cells or associated stromal cells are able to secrete factors such as VEGF-C and VEGF-D to induce lymphangiogenesis through VEGFR-3 activation in LECs, thereby providing access to more lymphatic vessels [60]. This evidence concerns the gene FLT4 and neoplasm.